SOURCE: INSYS Therapeutics

Insys Therapeutics

September 01, 2015 08:00 ET

Insys Therapeutics to Present at 10th Annual Wells Fargo Healthcare Conference

PHOENIX, AZ--(Marketwired - Sep 1, 2015) - Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ: INSY) today announced that Michael Babich, President and Chief Executive Officer, and Darryl Baker, Chief Financial Officer, will present at the 10th Annual Wells Fargo Healthcare Conference as follows:

Conference: Wednesday, September 9, 2015
Time: 8:50 a.m. EDT
Website: https://cc.talkpoint.com/well001/090915a_ae/?entity=16_IFB87IX

The presentation will be webcast live at the aforementioned time and site as well as archived for 90 days thereafter, via the Company's website at www.insysrx.com, under the Investors Section.

About Insys Therapeutics, Inc.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using proprietary sublingual spray technology and capabilities to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. The Company recently submitted a New Drug Application to the U.S. Food and Drug Administration for Dronabinol Oral Solution, a proprietary, orally administered liquid formulation of dronabinol that Insys believes has distinct advantages over the current formulation of dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual sprays, as well as synthetic pharmaceutical cannabidiol.